What is it?
5-amino-1MQ blocks the enzyme NNMT, which methylates compounds involved in detoxification and is active in various tissues, including the liver and brain. Increased NNMT activity is associated with diseases like cancer and Parkinson’s, making it a potential target for new therapies.
What does science research say?
Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice
Summary: NNMT inhibitors, including 5-amino-1MQ, reduced body weight, adipose tissue, and cholesterol levels in obese mice without impacting food intake. These inhibitors also increased NAD+ and SAM levels, highlighting NNMT as a promising target for obesity treatments.
Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes
Summary: NNMT inhibition has shown potential in managing obesity and type 2 diabetes by enhancing energy expenditure, reducing fat mass, and improving insulin sensitivity. This study highlights NNMT as a therapeutic target, though more research is needed to clarify mechanisms and develop clinical applications.
Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice
Summary: 5-amino-1MQ combined with a low-fat diet in obese mice led to distinct gut microbiome changes, promoting weight loss and metabolic regulation. Microbial diversity patterns indicated unique profiles in treated mice, linking NNMT inhibition to microbiome-driven metabolic benefits.
Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic
Summary: This study tested a 5-amino-1MQ analog for prostate cancer treatment, showing reduced tumor growth and low toxicity in mice. Results support its potential as a safe cancer therapy, targeting protein kinase C-iota pathways to inhibit tumor progression.
Discovery of Novel N-Nicotinamide Methyltransferase Inhibitors to Combat Obesity-Linked Osteoarthritis and Metabolic Disease Among Veterans and Beneficiaries
Summary: This study developed new NNMT inhibitors aimed at reducing white adipose tissue and alleviating obesity-linked conditions. Early results in obese mouse models showed promising reductions in adiposity, indicating potential for NNMT inhibitors in treating metabolic diseases and osteoarthritis.
What do user think?
*Based on large scale analysis of publicly available user experiences, the higher it is the better overall opinions of users on efficiency, safety, availability, etc.
Category: Mixed
User feedback on 5-Amino-1MQ is mixed, with some individuals experiencing significant weight loss and increased energy, while others report minimal or no effects.
Main insights
Effects |
|
Effectiveness |
|
Dosage & Administration |
|
Side Effects |
|
Availability & Sourcing |
|
How Our community rates it?
There are no reviews yet. Be the first one to write one.